N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial

Oral administration of N,N-Dimethylglycine (DMG), a tertiary amino acid, presumably enhances oxygen utilization by tissue and complex with free radicals. Beneficial effects are improved endurance performance and reduction fatigue in humans and animals. This pilot study reports the results over a one...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolfsegger, Thomas, Böck, Klaus, Schimetta, Wolfgang, von Oertzen, Tim J., Assar, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142643/
https://www.ncbi.nlm.nih.gov/pubmed/34024278
http://dx.doi.org/10.1186/s42466-021-00126-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142643/
https://www.ncbi.nlm.nih.gov/pubmed/34024278
http://dx.doi.org/10.1186/s42466-021-00126-z

Ejemplares similares